Overview
No overview information available.
Indication
抗肝素药。用于因注射肝素过量所引起的出血。
Associated Conditions
- Heparin overdose
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/02/12 | Not Applicable | Not yet recruiting | |||
2022/06/21 | Phase 4 | Completed | |||
2021/01/27 | Not Applicable | Completed | |||
2016/01/01 | N/A | Completed | |||
2011/03/08 | Not Applicable | UNKNOWN | |||
2010/12/28 | Phase 4 | Completed | SANE-Society of Anesthesiology | ||
2005/09/19 | Phase 4 | Completed | |||
2003/11/27 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Protamine Sulfate Injection | 国药准字H11020247 | 化学药品 | 注射剂（小容量注射剂） | 12/23/2022 | |
| Protamine Sulfate Injection | 国药准字H23021620 | 化学药品 | 注射剂 | 1/14/2024 | |
| Protamine Sulfate Injection | 国药准字H31020515 | 化学药品 | 注射剂 | 6/3/2020 | |
| Protamine Sulfate Injection | 国药准字H11020246 | 化学药品 | 注射剂（小容量注射剂） | 9/6/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.